Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

CLINICAL RESEARCH FRANCE : revenue, balance sheet and financial ratios

CLINICAL RESEARCH FRANCE is a French company founded 12 years ago, specialized in the sector Conseil pour les affaires et autres conseils de gestion. Based in BOULOGNE-BILLANCOURT (92100), this company of category PME shows in 2018 a net income positive of 34 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - CLINICAL RESEARCH FRANCE (SIREN 798499927)
Indicator 2018
Revenue N/C
Net income 33 769 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2018, CLINICAL RESEARCH FRANCE generates positive net income of 34 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2018) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

33 769 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 98%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2018) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2018) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

98.131%

Asset age ratio (2018) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

65.1%

Solvency indicators evolution
CLINICAL RESEARCH FRANCE

Sector positioning

Debt ratio
0.0 2018
2018
Q1: 0.0
Med: 4.48
Q3: 43.96
Excellent

In 2018, the debt ratio of CLINICAL RESEARCH FRANCE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
98.13% 2018
2018
Q1: 5.8%
Med: 39.4%
Q3: 72.72%
Excellent

In 2018, the financial autonomy of CLINICAL RESEARCH FRANCE (98.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 5304.02. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2018) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

5304.018

Liquidity indicators evolution
CLINICAL RESEARCH FRANCE

Sector positioning

Liquidity ratio
5304.02 2018
2018
Q1: 134.77
Med: 263.86
Q3: 637.17
Excellent

In 2018, the liquidity ratio of CLINICAL RESEARCH FRANCE (5304.02) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of CLINICAL RESEARCH FRANCE in its sector

Comparison with sector Conseil pour les affaires et autres conseils de gestion

Valuation estimate

Based on 69 transactions of similar company sales in 2018, the value of CLINICAL RESEARCH FRANCE is estimated at 130 506 € (range 54 518€ - 341 010€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2018
69 tx
54k€ 130k€ 341k€
130 506 € Range: 54 518€ - 341 010€
NAF 5 année 2018

Valuation method used

Net Income Multiple
33 769 € × 3.9x = 130 506 €
Range: 54 518€ - 341 010€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 69 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Conseil pour les affaires et autres conseils de gestion)

Compare CLINICAL RESEARCH FRANCE with other companies in the same sector:

Frequently asked questions about CLINICAL RESEARCH FRANCE

What is the revenue of CLINICAL RESEARCH FRANCE ?

The revenue of CLINICAL RESEARCH FRANCE is not publicly disclosed (confidential accounts filed with INPI).

Is CLINICAL RESEARCH FRANCE profitable?

Yes, CLINICAL RESEARCH FRANCE generated a net profit of 34 k€ in 2018.

Where is the headquarters of CLINICAL RESEARCH FRANCE ?

The headquarters of CLINICAL RESEARCH FRANCE is located in BOULOGNE-BILLANCOURT (92100), in the department Hauts-de-Seine.

Where to find the tax return of CLINICAL RESEARCH FRANCE ?

The tax return of CLINICAL RESEARCH FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does CLINICAL RESEARCH FRANCE operate?

CLINICAL RESEARCH FRANCE operates in the sector Conseil pour les affaires et autres conseils de gestion (NAF code 70.22Z). See the 'Sector positioning' section above to compare the company with its competitors.